We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

340B Program: Orphan Drug Exception—A Timeline of PhRMA's Legal Challenge to HRSA's Final Rule

05 February 2015

Health, Pharmaceutical, and Biotechnology Alert

On Wednesday, August 27, 2014, the U.S. District Court for the District of Columbia entered final judgment in the legal challenge to the final rule on the treatment of orphan drugs under the 340B Drug Pricing Program. That legal challenge, commenced in September 2013, followed a circuitous route that involved not only court filings but also public remarks by a government official—and their subsequent retraction. The following timeline outlines important events related to the legal challenge and includes links to relevant filings and other documents.

Read more: 340B Program: Orphan Drug Exception—A Timeline of PhRMA's Legal Challenge to HRSA's Final Rule

The team

Loading data